Skip to content

STARTbeforeCORT randomized controlled multicenter trial – STArt Respiratory sTabilization BEFORE umbilical CORd Transfusion (SBC) in extremely preterm infants: a randomized controlled multicentre trial of safety and efficiency

STARTbeforeCORT randomized controlled multicenter trial – STArt Respiratory sTabilization BEFORE umbilical CORd Transfusion (SBC) in extremely preterm infants: a randomized controlled multicentre trial of safety and efficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038162
Enrollment
238
Registered
2025-10-16
Start date
2026-10-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extreme prematurity (gestational age 22+0–27+6 weeks) with risk for major neonatal morbidities (IVH, BPD, NEC, ROP, cPVL).

Interventions

Group 1: STARTbeforeCORT (SBC): Start of respiratory stabilization before umbilical cord transfusion in preterm infants 22+0–27+6 weeks’ gestation. Group 2: Delayed Cord Clamping (DCC): Delayed clampi

Sponsors

Universitätsklinikum Ulm, Klinik für Kinder-und Jugendmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Preterm infants born between 22+0 and 27+6 weeks’ gestation Birth till max. 1 hour after birth (time window for study inclusion) Written informed consent of parents or legal guardian

Exclusion criteria

Exclusion criteria: Spontaneous vaginal delivery Emergency delivery with insufficient time for informed consent Non-lastborn multiple Severe congenital malformations (neurological, pulmonary, cardiac) Decision for palliative care only Parents unable to understand study information due to language barriers

Design outcomes

Primary

MeasureTime frame
Occurrence of any acute severe morbidity (IVH > grade 2, cPVL, NEC > stage 1, moderate/severe BPD, or ROP > stage 2) until discharge or 36 weeks’ postmenstrual age, whichever occurs first.

Secondary

MeasureTime frame
Very early and early mortality, individual severe morbidities (IVH, cPVL, NEC, BPD, ROP), need for resuscitation, intubation, transfusions, circulatory therapy, duration of oxygen and respiratory support, somatic growth, neurodevelopmental and psychomotor outcome at 24 and 60 months corrected age, quality of life (PedsQL), social participation (YC-PEM), pulmonary health (ASQ3 questionnaires).

Countries

Germany

Contacts

Public ContactHarald Ehrhardt

Universitätsklinik Ulm, Klinik für Kinder- und Jugendmedizin

harald.ehrhardt@uniklinik-ulm.de+49 731 500 57168

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026